Literature DB >> 19923265

Deletion of the rat cytomegalovirus immediate-early 1 gene results in a virus capable of establishing latency, but with lower levels of acute virus replication and latency that compromise reactivation efficiency.

Gordon R Sandford1, Uwe Schumacher, Jakob Ettinger, Wolfram Brune, Gary S Hayward, William H Burns, Sebastian Voigt.   

Abstract

The immediate-early 1 (IE1) and IE2 proteins encoded by the major immediate-early (MIE) transcription unit of cytomegaloviruses are thought to play key roles in the switch between latent- and lytic-cycle infection. Whilst IE2 is essential for triggering the lytic cycle, the exact roles of IE1 have not been resolved. An MIE-exon 4-deleted rat cytomegalovirus (DeltaIE1) failed to synthesize the IE1 protein and did not disperse promyelocytic leukaemia bodies early post-infection, but was still capable of normal replication in fibroblast cell culture. However, DeltaIE1 had a diminished ability to infect salivary glands persistently in vivo and to reactivate from spleen explant cultures ex vivo. Quantification of viral genomes in spleens of infected animals revealed a reduced amount of DeltaIE1 virus produced during acute infection, suggesting a role for IE1 as a regulator in establishing a chronic or persistent infection, rather than in influencing the latency or reactivation processes more directly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923265      PMCID: PMC3192538          DOI: 10.1099/vir.0.016022-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.

Authors:  J H Ahn; G S Hayward
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

2.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.

Authors:  A Marchini; H Liu; H Zhu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics.

Authors:  G R Sandford; L E Brock; S Voigt; C M Forester; W H Burns
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.

Authors:  Andreas Busche; Anja Marquardt; Andre Bleich; Peter Ghazal; Ana Angulo; Martin Messerle
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 7.  Mouse models of cytomegalovirus latency: overview.

Authors:  Matthias J Reddehase; Jürgen Podlech; Natascha K A Grzimek
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

8.  Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression.

Authors:  Elizabeth A White; Charles L Clark; Veronica Sanchez; Deborah H Spector
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.

Authors:  Hye-Ra Lee; Do-Jun Kim; Jang-Mi Lee; Cheol Yong Choi; Byung-Yoon Ahn; Gary S Hayward; Jin-Hyun Ahn
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection.

Authors:  Qiyi Tang; Gerd G Maul
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  6 in total

1.  The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Authors:  Julia Hornig; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-02-10       Impact factor: 3.616

2.  Mutations in the M112/M113-coding region facilitate murine cytomegalovirus replication in human cells.

Authors:  Uwe Schumacher; Wiebke Handke; Igor Jurak; Wolfram Brune
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

3.  Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ.

Authors:  Theresa Knoblach; Benedikt Grandel; Jana Seiler; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

4.  Human cytomegalovirus infection and colorectal cancer risk: a meta-analysis.

Authors:  Bingjun Bai; Xingxing Wang; Engeng Chen; Hongbo Zhu
Journal:  Oncotarget       Date:  2016-11-22

Review 5.  Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.

Authors:  Catherine S Adamson; Michael M Nevels
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

6.  Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection.

Authors:  Sara Rodríguez-Martín; Kai Alexander Kropp; Vanessa Wilhelmi; Vanda Juranic Lisnic; Wei Yuan Hsieh; Mathieu Blanc; Andrew Livingston; Andreas Busche; Hille Tekotte; Martin Messerle; Manfred Auer; Iain Fraser; Stipan Jonjic; Ana Angulo; Matthias J Reddehase; Peter Ghazal
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.